
  
    
      
        Background_NNP
        Diabetes_NNP mellitus_JJ predisposes_NNS individuals_NNS to_TO bacterial_JJ
        and_CC fungal_NN infections_NNS ,_, including_VBG those_DT caused_VBN by_IN 
        Candida_NNP species_NNS ._. Many_JJ investigators_NNS
        have_VBP suggested_VBN that_IN vulvovaginal_NN candidiasis_NNS (_( VVC_NNP )_) occurs_VBZ
        more_RBR frequently_RB in_IN diabetics_NNS [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD ]_NN ._. Further_RB ,_,
        chronic_JJ recurring_VBG VVC_NNP may_MD be_VB a_DT marker_NN of_IN diabetes_NN [_NN 9_CD ]_NN ._.
        Several_JJ studies_NNS report_VBP increased_VBN rates_NNS of_IN asymptomatic_JJ
        vaginal_JJ carriage_NN rates_NNS of_IN 
        Candida_NNP species_NNS and_CC incidence_NN of_IN
        symptomatic_JJ infection_NN in_IN diabetic_JJ women_NNS ,_, but_CC results_NNS are_VBP
        inconsistent_JJ [_NN 5_CD 10_CD 11_CD 12_CD 13_CD 14_CD ]_NN ._. While_IN some_DT show_NN no_DT
        increase_NN in_IN carriage_NN of_IN vaginal_JJ 
        Candida_NNP [_NN 5_CD ]_NN ,_, those_DT demonstrating_VBG
        increased_VBN 
        Candida_NNP carriage_NN in_IN female_JJ diabetes_NN
        patients_NNS do_VBP not_RB examine_VB the_DT effect_NN of_IN glucose_NN control_NN or_CC
        diabetes_NN type_NN [_NN 12_CD 14_CD ]_NN ._. However_RB ,_, 
        in_IN vitro_NN studies_NNS demonstrating_VBG
        impaired_VBN host_NN response_NN directed_VBN against_IN 
        Candida_NNP in_IN diabetics_NNS support_VBP the_DT idea_NN
        of_IN increased_VBN rates_NNS of_IN 
        Candida_NNP colonization_NN among_IN diabetics_NNS
        [_NN 4_CD 6_CD 7_CD ]_NN ._. Whether_IN diabetes_NN leads_VBZ to_TO more_RBR symptomatic_JJ
        and_CC /_NN or_CC more_RBR recurrent_JJ VVC_NNP episodes_NNS is_VBZ a_DT subject_NN of_IN
        controversy_NN ._.
        Potential_JJ risk_NN factors_NNS for_IN VVC_NNP include_VBP diabetes_NN type_NN ,_,
        severity_NN ,_, and_CC degree_NN of_IN glucose_NN control_NN ._. [_NN 26_CD 27_CD 28_CD 29_CD 30_CD ]_NN
        In_IN addition_NN to_TO diabetes_NN mellitus_JJ ,_, a_DT number_NN of_IN VVC_NNP risk_NN
        factors_NNS have_VBP been_VBN identified_VBN ,_, including_VBG African-_NNP American_JJ
        heritage_NN [_NN 15_CD 16_CD 17_CD ]_NN ,_, previous_JJ history_NN of_IN VVC_NNP [_NN 15_CD ]_NN ,_,
        higher_JJR education_NN degree_NN ,_, intermediate_JJ age_NN ,_, oral_JJ
        contraceptive_JJ pills_NNS [_NN 3_CD 10_CD 16_CD 18_CD ]_NN ,_, use_NN of_IN commercially_RB
        available_JJ solutions_NNS for_IN cleansing_NN of_IN external_JJ genitalia_NN or_CC
        vaginal_JJ douching_VBG ,_, frequent_JJ sexual_JJ intercourse_NN [_NN 17_CD 19_CD 10_CD ]_NN
        ,_, sexual_JJ behavior_NN (_( age_NN at_IN first_JJ intercourse_NN ,_, frequency_NN of_IN
        oral-genital_JJ contact_NN )_) [_NN 20_CD ]_NN ,_, contraception_NN devices_NNS
        (_( diaphragm_NN ,_, vaginal_JJ contraceptive_JJ sponge_NN ,_, intrauterine_JJ
        device_NN )_) ,_, and_CC antibiotics_NNS [_NN 3_CD 15_CD 19_CD ]_NN ._. Whether_IN these_DT
        factors_NNS increase_VBP risk_NN of_IN 
        Candida_NNP colonization_NN or_CC symptomatic_JJ
        infection_NN following_VBG colonization_NN ,_, or_CC both_DT ,_, is_VBZ unknown_JJ ,_,
        however_RB ,_, it_PRP should_MD be_VB emphasized_VBN that_IN a_DT prerequisite_NN for_IN
        symptomatic_JJ vaginitis_NNS is_VBZ vaginal_JJ colonization_NN ._.
        Few_JJ studies_NNS have_VBP addressed_VBN the_DT relationship_NN between_IN 
        Candida_NNP colonization_NN ,_, VVC_NNP ,_, and_CC
        diabetes_NN ;_: none_NN we_PRP are_VBP aware_JJ of_IN have_VBP examined_VBN the_DT role_NN of_IN
        behavioral_JJ VVC_NNP risk_NN factors_NNS for_IN colonization_NN among_IN persons_NNS
        with_IN diabetes_NN ._. To_TO evaluate_VB the_DT relationship_NN between_IN 
        Candida_NNP colonization_NN and_CC hypothesized_VBN
        risk_NN factors_NNS for_IN vulvovaginal_NN candidiasis_NNS colonization_NN in_IN
        diabetics_NNS ,_, we_PRP conducted_VBD a_DT cross-sectional_JJ study_NN among_IN
        female_JJ diabetes_NN patients_NNS receiving_VBG care_NN at_IN one_CD of_IN two_CD
        diabetes_NN clinics_NNS ._. We_PRP describe_VBP the_DT associations_NNS between_IN 
        Candida_NNP colonization_NN ,_,
        sociodemographics_NNS ,_, health_NN behaviors_NNS ,_, diabetes_NN type_NN ,_,
        diabetes_NN severity_NN ,_, and_CC Hemoglobin_NNP A_DT 
        1_CD c_SYM level_NN among_IN women_NNS with_IN type_NN 1_CD and_CC
        type_NN 2_CD diabetes_NN ._.
      
      
        Methods_NNP
        
          Study_NN population_NN
          Female_NNP diabetes_NN patients_NNS seen_VBN at_IN an_DT outpatient_NN
          academic_JJ diabetes_NN practice_NN of_IN Wayne_NNP State_NNP University_NNP
          Division_NNP of_IN Endocrinology_NNP ,_, Department_NNP of_IN Internal_NNP
          Medicine_NNP ,_, were_VBD eligible_JJ for_IN study_NN ._. The_DT practice_NN included_VBD
          an_DT urban_JJ (_( University_NNP Health_NNP Center_NNP ,_, Detroit_NNP ,_, MI_NNP )_) clinic_NN
          and_CC a_DT suburban_JJ clinic_NN (_( Hechtman_NNP Clinic_NNP ,_, Bingham_NNP Farms_NNP ,_,
          MI_NNP )_) ._. Patients_NNS were_VBD diagnosed_VBN with_IN type_NN 1_CD and_CC type_NN 2_CD
          diabetes_NN on_IN clinical_JJ presentation_NN by_IN a_DT board_NN certified_VBN
          endocrinologist_NN ._. Potential_JJ participants_NNS were_VBD approached_VBN
          in_IN the_DT clinic_NN waiting_VBG room_NN and_CC consent_NN obtained_VBN ._. As_IN an_DT
          incentive_NN for_IN participation_NN ,_, subjects_NNS were_VBD rewarded_VBN with_IN
          video_NN rental_JJ gift_NN certificates_NNS (_( value_NN $_$ 5_LS )_) ._. Participants_NNS
          consented_VBD to_TO a_DT medical_JJ record_NN review_NN which_WDT included_VBD
          abstraction_NN of_IN total_JJ glycated_JJ hemoglobin_NN levels_NNS obtained_VBN
          at_IN the_DT enrollment_NN visit_NN ,_, completed_VBD a_DT self-administered_JJ
          questionnaire_NN and_CC self-collected_JJ a_DT vaginal_JJ swab_NN ._. The_DT
          questionnaire_NN addressed_VBD the_DT following_JJ variables_NNS :_:
          sociodemographic_JJ (_( age_NN ,_, race_NN ,_, marital_JJ status_NN ,_, insurance_NN
          status_NN ,_, highest_JJS education_NN completed_VBD ,_, occupation_NN )_) ;_:
          diabetes_NN duration_NN ,_, type_NN ,_, severity_NN ,_, and_CC abnormal_JJ glucose_NN
          level_NN ;_: lifetime_NN history_NN of_IN physician_NN diagnosed_VBD VVC_NNP
          episodes_NNS ;_: recent_JJ antibiotic_JJ use_NN ,_, by_IN type_NN ;_: sexual_JJ history_NN ;_:
          health_NN behaviors_NNS ._. For_IN the_DT diabetes_NN section_NN we_PRP used_VBD
          questions_NNS from_IN the_DT Diabetes_NNP Care_NNP Profile_NNP ,_, an_DT instrument_NN
          developed_VBN and_CC validated_JJ by_IN the_DT Michigan_NNP Diabetes_NNP Research_NNP
          and_CC Training_NNP Center_NNP [_NN 21_CD 22_CD ]_NN ._. The_DT study_NN protocol_NN was_VBD
          approved_VBN by_IN the_DT Institutional_NNP Review_NNP Boards_NNP at_IN the_DT
          University_NNP of_IN Michigan_NNP and_CC Wayne_NNP State_NNP University_NNP ._.
          Of_IN 155_CD women_NNS approached_VBN ,_, 105_CD (_( 67_CD ._. 7_CD %_NN )_) consented_VBD ._. One_CD
          woman_NN was_VBD ineligible_JJ because_IN her_PRP$ vaginal_JJ sample_NN was_VBD lost_VBN ._.
          Two_CD women_NNS decided_VBD to_TO stop_VB participating_VBG during_IN the_DT study_NN ;_:
          one_CD did_VBD not_RB understand_VB the_DT questionnaire_NN ,_, while_IN the_DT other_JJ
          felt_VBD the_DT questionnaire_NN was_VBD too_RB intrusive_JJ ,_, leaving_VBG a_DT final_JJ
          sample_NN size_NN of_IN 101_CD participants_NNS ._.
        
        
          Laboratory_NN methods_NNS
          All_DT vaginal_JJ specimens_NNS were_VBD cultured_JJ for_IN yeast_NN ._.
          Specimens_NNP were_VBD placed_VBN on_IN plates_NNS with_IN media_NNS selective_JJ for_IN 
          Candida_NNP growth_NN (_( Sabouraud_NNP 's_POS
          dextrose_NN agar_NN )_) ._. Suspected_NNP mixed_JJ samples_NNS ,_, as_IN determined_VBN by_IN
          colony_NN type_NN and_CC microscopic_JJ characteristics_NNS ,_, were_VBD placed_VBN
          on_IN plates_NNS with_IN media_NNS showing_VBG species-specific_JJ colony_NN
          color_NN change_NN (_( Chromagar_NNP ,_, CHROMagar_NNP ,_, Paris_NNP ,_, France_NNP )_) ._. 
          C_NNP ._. albicans_NNS and_CC 
          C_NNP ._. glabrata_NN were_VBD identified_VBN by_IN
          chlamydospore_NN and_CC germ_NN tube_NN tests_NNS ;_: all_DT other_JJ species_NNS were_VBD
          identified_VBN by_IN carbohydrate_NN assimilation_NN tests_NNS (_( API-_NNP 20_CD C_NNP
          AUX_NNP )_) ._.
        
        
          Data_NNP analysis_NN
          We_PRP described_VBD the_DT distributions_NNS of_IN hypothesized_VBN
          variables_NNS among_IN participants_NNS ,_, using_VBG simple_JJ descriptive_JJ
          statistics_NNS ,_, and_CC the_DT associations_NNS between_IN hypothesized_VBN
          risk_NN factors_NNS and_CC 
          Candida_NNP colonization_NN using_VBG odds_NNS
          ratios_NNS (_( OR_NNP )_) and_CC Cornfield_NNP 95_CD %_NN confidence_NN intervals_NNS (_( CI_NNP )_) ._.
          After_IN a_DT detailed_VBN stratified_JJ analysis_NN ,_, to_TO assess_VB
          confounding_VBG and_CC effect_NN modification_NN ,_, we_PRP fit_VBP a_DT logistic_JJ
          regression_NN model_NN for_IN 
          Candida_NNP carriage_NN ._. We_PRP calculated_VBD ORS_NNP
          and_CC 95_CD %_NN CIs_NNP for_IN the_DT bivariate_NN analyses_NNS using_VBG EpiInfo_NNP [_NN 23_CD
          ]_NN ;_: all_DT other_JJ analyses_NNS and_CC data_NNS management_NN were_VBD done_VBN
          using_VBG SAS_NNP [_NN 24_CD ]_NN ._. Several_JJ variables_NNS strongly_RB associated_VBN
          with_IN 
          Candida_NNP colonization_NN had_VBD small_JJ
          numbers_NNS of_IN missing_VBG values_NNS ,_, particularly_RB for_IN oral_JJ sex_NN
          (_( 13_CD %_NN )_) and_CC douching_VBG (_( 9_CD %_NN )_) (_( others_NNS did_VBD not_RB exceed_VB 5_CD %_NN )_) ._. In_IN
          this_DT case_NN ,_, for_IN the_DT multivariate_NN analyses_NNS ,_, we_PRP inferred_VBN
          that_IN a_DT missing_VBG response_NN was_VBD equivalent_JJ to_TO a_DT negative_JJ
          response_NN ._. If_IN we_PRP are_VBP wrong_JJ in_IN this_DT inference_NN ,_, the_DT
          resulting_VBG estimates_NNS will_MD be_VB biased_VBN towards_IN the_DT null_NN
          hypothesis_NNS of_IN no_DT effect_NN ._. Excluding_VBG the_DT missing_VBG responses_NNS
          from_IN the_DT relevant_JJ analyses_NNS only_RB modestly_RB changed_VBD the_DT
          point_NN estimates_NNS ._.
        
      
      
        Results_NNS
        
          Demographic_NNP characteristics_NNS by_IN clinic_NN
          Fifty-nine_NNP participants_NNS were_VBD recruited_VBN from_IN UHC_NNP ;_:
          forty-two_JJ were_VBD recruited_VBN from_IN Hechtman_NNP ._. Mean_VB age_NN among_IN
          UHC_NNP participants_NNS was_VBD 52_CD ._. 3_LS years_NNS ,_, while_IN mean_NN age_NN among_IN
          Hechtman_NNP participants_NNS was_VBD 50_CD ._. 0_CD years_NNS (_( p_NN =_SYM 0_CD ._. 5_LS )_) ._. The_DT
          clinics_NNS varied_VBD greatly_RB ,_, however_RB ,_, in_IN participant_NN
          ethnicity_NN ._. Forty_CD of_IN fifty-nine_JJ (_( 67_CD ._. 8_CD %_NN )_) UHC_NNP participants_NNS
          were_VBD of_IN African_NNP American_JJ descent_NN ._. By_IN contrast_NN ,_, eight_CD of_IN
          42_CD (_( 19_CD ._. 0_CD %_NN )_) Hechtman_NNP participants_NNS were_VBD of_IN African_NNP American_JJ
          descent_NN ._.
        
        
          Diabetes_NNP characteristics_NNS
          Most_JJS participants_NNS had_VBD type_NN 2_CD diabetes_NN (_( 62_CD /_NN 101_CD =_SYM 61_CD %_NN )_) ._.
          By_IN clinic_NN ,_, type_NN 2_CD was_VBD more_RBR common_JJ among_IN UHC_NNP participants_NNS
          (_( 69_CD %_NN )_) ,_, but_CC was_VBD equally_RB distributed_VBN among_IN Hechtman_NNP
          participants_NNS ._.
          Total_JJ glycated_JJ hemoglobin_NN levels_NNS measured_VBN at_IN the_DT time_NN
          of_IN the_DT enrollment_NN visit_NN were_VBD abstracted_JJ from_IN patient_NN 's_POS
          charts_NNS ._. We_PRP assessed_VBD glycemia_NN by_IN transforming_VBG total_JJ
          glycated_JJ hemoglobin_NN levels_NNS to_TO hemoglobin_NN A_DT 1_CD c_SYM (_( HbA_NNP 
          1_CD c_SYM )_) values_NNS using_VBG a_DT linear_JJ regression_NN
          formula_NN [_NN 25_CD ]_NN ._. For_IN the_DT Wayne_NNP State_NNP University_NNP patient_NN
          population_NN ,_, a_DT value_NN of_IN HbA_NNP 
          1_CD c_SYM >_NN 6_CD ._. 4_CD %_NN is_VBZ abnormal_JJ ._. This_DT
          cutpoint_NN was_VBD determined_VBN by_IN standard_JJ clinical_JJ laboratory_NN
          comparison_NN methods_NNS and_CC verification_NN of_IN the_DT reference_NN
          interval_NN [_NN 26_CD 27_CD 28_CD 29_CD 30_CD ]_NN ._. The_DT mean_NN HbA_NNP 
          1_CD c_SYM for_IN our_PRP$ study_NN population_NN was_VBD 7_CD ._. 91_CD ,_,
          with_IN a_DT range_NN of_IN 4_CD ._. 4_CD -_: 15_CD ._. 7_CD ._. Overall_RB ,_, only_RB 20_CD of_IN 101_CD
          participants_NNS (_( 19_CD ._. 8_CD %_NN )_) had_VBD normal_JJ HbA_NNP 
          1_CD c_SYM at_IN time_NN of_IN enrollment_NN ._. Type_NNP 1_CD
          subjects_NNS had_VBD a_DT higher_JJR proportion_NN of_IN abnormal_JJ levels_NNS
          (_( 92_CD ._. 3_LS %_NN )_) than_IN type_NN 2_CD subjects_NNS (_( 72_CD ._. 6_CD %_NN )_) (_( p_NN =_SYM 0_CD ._. 02_CD )_) ._.
        
        
          Correlates_NNP of_IN Candidacolonization_NNP
          29_CD of_IN 101_CD (_( 28_CD ._. 7_CD %_NN )_) participants_NNS were_VBD colonized_JJ with_IN 
          Candida_NNP species_NNS ._. 2_LS of_IN the_DT 29_CD (_( 6_CD ._. 9_CD %_NN )_)
          were_VBD colonized_JJ with_IN two_CD 
          Candida_NNP species_NNS ._. The_DT most_RBS common_JJ
          species_NNS were_VBD 
          C_NNP ._. albicans_NNS (_( 12_CD /_NN 29_CD =_SYM 41_CD ._. 4_LS %_NN )_) and_CC 
          C_NNP ._. glabrata_NN (_( 11_CD /_NN 29_CD =_SYM 37_CD ._. 9_CD %_NN )_) ._. 
          C_NNP ._. albicans_NNS predominated_JJ among_IN
          women_NNS with_IN type_NN 1_CD (_( 9_CD /_NN 16_CD colonized_JJ or_CC 56_CD %_NN )_) and_CC 
          C_NNP ._. glabrata_NN among_IN women_NNS with_IN Type_NNP 2_CD
          (_( 7_CD /_NN 13_CD colonized_JJ or_CC 54_CD %_NN )_) ._. We_PRP identified_VBD one_CD isolate_VB of_IN 
          C_NNP ._. parapsilosis_NNS ,_, C_NNP ._.
          guilliermondii_NN ,_, and_CC 
          Trichosporon_NNP beigelli_NN ._. 
          Type_NNP 1_CD patients_NNS were_VBD more_RBR likely_JJ to_TO be_VB colonized_JJ with_IN 
          Candida_NNP than_IN type_NN 2_CD patients_NNS (_( OR_NNP =_SYM
          2_CD ._. 6_CD ;_: 95_CD %_NN CI_NNP :_: 0_CD ._. 99_CD ,_, 6_CD ._. 98_CD ;_: p_NN =_SYM 0_CD ._. 03_CD )_) (_( Table_NNP 1_LS )_) ._. Women_NNS with_IN
          abnormal_JJ HbA_NNP 
          1_CD c_SYM were_VBD almost_RB three_CD times_NNS more_RBR likely_JJ
          to_TO be_VB colonized_JJ with_IN 
          Candida_NNP than_IN those_DT with_IN normal_JJ HBA_NNP 
          1_CD c_SYM ,_, but_CC this_DT association_NN was_VBD not_RB
          statistically_RB significant_JJ (_( OR_NNP =_SYM 2_CD ._. 7_CD ;_: 95_CD %_NN CI_NNP :_: 0_CD ._. 68_CD ,_, 15_CD ._. 39_CD ;_:
          p_NN =_SYM 0_CD ._. 13_CD )_) ._. No_DT statistically_RB significant_JJ association_NN was_VBD
          detected_VBN between_IN 
          Candida_NNP colonization_NN and_CC duration_NN
          of_IN diabetes_NN ,_, although_IN those_DT who_WP were_VBD colonized_JJ in_IN each_DT
          diabetic_JJ type_NN tended_VBD to_TO have_VB longer_JJR duration_NN of_IN diabetes_NN
          (_( mean_VB duration_NN diabetes_NN ,_, colonized_JJ v_NN ._. not_RB :_: type_NN 1_CD :_: 15_CD ._. 7_CD
          v_NN ._. 20_CD ._. 2_LS y_NN ,_, p_NN =_SYM 0_CD ._. 34_CD ;_: type_NN 2_CD :_: 9_CD ._. 8_CD v_NN ._. 16_CD ._. 1_LS y_NN ,_, p_NN =_SYM 0_CD ._. 28_CD )_) ._.
          Average_JJ duration_NN of_IN diabetes_NN among_IN colonized_JJ women_NNS did_VBD
          not_RB differ_VB by_IN type_NN (_( type_NN 1_CD :_: 20_CD ._. 2_LS v_NN ._. type_NN 2_CD :_: 16_CD ._. 1_LS ;_: p_NN =_SYM
          0_CD ._. 53_CD )_) ._.
          Age_NNP ,_, race_NN ,_, marital_JJ status_NN ,_, education_NN ,_, and_CC employment_NN
          were_VBD not_RB significantly_RB associated_VBN with_IN 
          Candida_NNP colonization_NN (_( Table_NNP 1_LS )_) ._.
          Antibiotic_NNP use_NN in_IN the_DT past_JJ 2_CD weeks_NNS ,_, lifetime_NN history_NN of_IN
          chlamydia_NN ,_, douching_VBG ,_, and_CC report_NN of_IN both_DT performing_VBG and_CC
          receiving_VBG oral_JJ sex_NN in_IN the_DT last_JJ two_CD weeks_NNS were_VBD strongly_RB
          associated_VBN with_IN 
          Candida_NNP colonization_NN ,_, whereas_IN
          vaginal-penile_JJ sex_NN had_VBD only_RB a_DT modest_JJ and_CC not_RB
          statistically_RB significant_JJ assocation_NN with_IN 
          Candida_NNP colonization_NN ._. When_WRB
          stratified_JJ by_IN oral_JJ sex_NN ,_, there_EX was_VBD no_DT association_NN between_IN
          vaginal_JJ sex_NN and_CC colonization_NN status_NN ._. However_RB ,_, the_DT effect_NN
          of_IN oral_JJ sex_NN remained_VBD after_IN stratification_NN by_IN vaginal_JJ
          sex_NN ._.
        
        
          Multivariate_NNP Analyses_NNS
          To_TO simultaneously_RB adjust_VB for_IN variables_NNS independently_RB
          associated_VBN with_IN 
          Candida_NNP colonization_NN in_IN the_DT crude_NN
          analyses_NNS ,_, we_PRP fit_VBP a_DT logistic_JJ regression_NN model_NN predicting_VBG 
          Candida_NNP carriage_NN (_( Table_NNP 2_LS )_) ._. Because_IN
          of_IN the_DT small_JJ sample_NN size_NN ,_, we_PRP created_VBD a_DT base_NN model_NN
          including_VBG age_NN ,_, diabetes_NN type_NN ,_, abnormal_JJ HbA_NNP 
          1_CD c_SYM ,_, recent_JJ antibiotic_JJ use_NN ,_, and_CC
          performing_VBG oral_JJ sex_NN ._. We_PRP assumed_VBD for_IN this_DT analysis_NN that_IN
          those_DT who_WP did_VBD not_RB respond_VB to_TO questions_NNS about_IN oral_JJ sex_NN did_VBD
          not_RB engage_VB in_IN oral_JJ sex_NN ._. Receiving_NNP oral_JJ sex_NN was_VBD not_RB
          associated_VBN after_IN adjustment_NN for_IN performing_VBG oral_JJ sex_NN (_( OR_NNP =_SYM
          1_CD ._. 07_CD ;_: 95_CD %_NN CI_NNP :_: 0_CD ._. 12_CD ,_, 9_CD ._. 42_CD ,_, p_NN =_SYM 0_CD ._. 95_CD )_) and_CC thus_RB was_VBD
          excluded_VBN from_IN the_DT base_NN model_NN ._. Other_JJ variables_NNS associated_VBN
          in_IN the_DT bivariate_NN analyses_NNS were_VBD added_VBN one_CD at_IN a_DT time_NN to_TO the_DT
          base_NN model_NN ._. After_IN adjustment_NN ,_, older_JJR age_NN ,_, having_VBG type_NN 1_CD
          diabetes_NN ,_, an_DT abnormal_JJ HbA_NNP 
          1_CD c_SYM level_NN ,_, and_CC report_NN of_IN antibiotic_JJ use_NN
          during_IN the_DT previous_JJ 2_CD weeks_NNS were_VBD statistically_RB
          significantly_RB associated_VBN with_IN 
          Candida_NNP colonization_NN ._. Performing_VBG
          oral_JJ sex_NN was_VBD associated_VBN with_IN an_DT almost_RB fivefold_JJ increase_NN
          in_IN colonization_NN ,_, but_CC the_DT association_NN was_VBD not_RB
          statistically_RB significant_JJ (_( p_NN =_SYM 0_CD ._. 08_CD )_) ._. When_WRB added_VBD
          individually_RB to_TO the_DT base_NN model_NN ,_, lifetime_NN history_NN of_IN
          chlamydia_NN (_( OR_NNP =_SYM 5_CD ._. 8_CD ;_: 95_CD %_NN CI_NNP :_: 10_CD ._. 9_CD ,_, 30_CD ._. 54_CD )_) but_CC not_RB
          douching_VBG (_( OR_NNP =_SYM 2_CD ._. 2_CD ;_: 95_CD %_NN CI_NNP :_: 0_CD ._. 68_CD ,_, 7_CD ._. 00_CD )_) remained_VBD
          strongly_RB associated_VBN with_IN colonization_NN ._. Four_CD participants_NNS
          positive_JJ for_IN 
          Candida_NNP also_RB had_VBD a_DT previous_JJ
          chlamydia_NN diagnosis_NN and_CC reported_VBD douching_VBG ._. When_WRB entered_VBD
          simultaneously_RB into_IN the_DT model_NN ,_, the_DT estimates_NNS were_VBD
          unstable_JJ ,_, thus_RB ,_, they_PRP were_VBD entered_VBN separately_RB ._. Douching_NNP
          and_CC history_NN of_IN chlamydia_NN were_VBD also_RB strongly_RB associated_VBN
          with_IN performing_VBG oral_JJ sex_NN ;_: adding_VBG each_DT of_IN these_DT variables_NNS
          reduced_VBD the_DT parameter_NN estimate_NN and_CC statistical_JJ
          significance_NN of_IN the_DT association_NN with_IN performing_VBG oral_JJ sex_NN ._.
          Pregnancy_NNP history_NN had_VBD no_DT association_NN with_IN colonization_NN
          after_IN adjustment_NN (_( OR_NNP =_SYM 0_CD ._. 97_CD ;_: 95_CD %_NN CI_NNP :_: 0_CD ._. 26_CD ,_, 3_CD ._. 66_CD )_) ._.
        
      
      
        Discussion_NNP
        Among_IN women_NNS with_IN diabetes_NN ,_, 
        Candida_NNP carriage_NN increased_VBD with_IN older_JJR
        age_NN ,_, type_NN 1_CD diabetes_NN ,_, abnormal_JJ HbA_NNP 
        1_CD c_SYM level_NN ,_, oral_JJ antibiotic_JJ use_NN in_IN the_DT
        previous_JJ two_CD weeks_NNS ,_, and_CC ever_RB history_NN of_IN chlamydia_NN ._. Other_JJ
        VVC_NNP risk_NN factors_NNS ,_, including_VBG African_NNP American_JJ descent_NN ,_,
        lifetime_NN history_NN of_IN VVC_NNP ,_, higher_JJR education_NN ,_, oral_JJ
        contraceptive_JJ use_NN ,_, and_CC frequency_NN of_IN vaginal_JJ intercourse_NN
        were_VBD not_RB significantly_RB associated_VBN with_IN 
        Candida_NNP colonization_NN after_IN adjustment_NN
        for_IN other_JJ variables_NNS ._. These_DT data_NNS suggest_VBP that_IN behavioral_JJ
        factors_NNS ,_, as_RB well_RB as_IN HbA_NNP 
        1_CD c_SYM ,_, are_VBP important_JJ determinants_NNS of_IN 
        Candida_NNP colonization_NN among_IN women_NNS with_IN
        diabetes_NN ._.
        Women_NNS with_IN type_NN 1_CD diabetes_NN had_VBD higher_JJR 
        Candida_NNP colonization_NN rates_NNS than_IN those_DT
        with_IN type_NN 2_CD ,_, even_RB after_IN adjusting_VBG for_IN age_NN ,_, behavioral_JJ
        factors_NNS and_CC HbA_NNP 
        1_CD c_SYM ._. One_CD possible_JJ explanation_NN is_VBZ
        difference_NN in_IN duration_NN of_IN 
        Candida_NNP carriage_NN :_: women_NNS with_IN type_NN 1_CD
        and_CC type_NN 2_CD diabetes_NN may_MD be_VB equally_RB likely_JJ to_TO acquire_VB 
        Candida_NNP ,_, but_CC those_DT with_IN type_NN 1_CD may_MD be_VB
        less_RBR able_JJ to_TO clear_VB it_PRP ._. Similar_JJ to_TO previous_JJ reports_NNS ,_, 
        C_NNP ._. albicans_NNS was_VBD isolated_VBN from_IN the_DT
        majority_NN of_IN colonized_JJ type_NN 1_CD participants_NNS ,_, while_IN 
        C_NNP ._. glabrata_NN was_VBD the_DT most_RBS common_JJ
        isolate_VB in_IN type_NN 2_CD participants_NNS ,_, but_CC our_PRP$ numbers_NNS are_VBP small_JJ [_NN
        1_CD ]_NN ._. Whether_IN this_DT is_VBZ due_JJ to_TO diabetes_NN type_NN or_CC reflects_VBZ
        different_JJ distributions_NNS of_IN 
        Candida_NNP species_NNS by_IN age_NN or_CC both_DT is_VBZ
        uncertain_JJ ._.
        The_DT observation_NN that_DT hyperglycemia_NN in_IN type_NN 1_CD diabetes_NN
        increases_NNS risk_VBP for_IN 
        Candida_NNP colonization_NN is_VBZ consistent_JJ
        with_IN previous_JJ reports_NNS [_NN 1_CD 5_CD 6_CD 31_CD ]_NN ._. A_DT New_NNP Zealand_NNP study_NN of_IN
        124_CD women_NNS with_IN type_NN 1_CD diabetes_NN found_VBD 7_CD of_IN 7_CD women_NNS with_IN
        elevated_VBD glycated_JJ hemoglobin_NN reported_VBD vaginal_JJ symptoms_NNS for_IN
        the_DT previous_JJ year_NN ,_, compared_VBN with_IN 60_CD %_NN overall_JJ [_NN 10_CD ]_NN ._.
        Hyperglycemia_NNP limits_NNS neutrophil_NN function_NN among_IN persons_NNS with_IN
        type_NN 1_CD diabetes_NN ,_, including_VBG neutrophils_NNS '_POS ability_NN to_TO
        phagocytose_NN and_CC kill_VB 
        Candida_NNP organisms_NNS ._. With_IN the_DT oxidative_JJ
        killing_NN ability_NN of_IN neutrophils_NNS hindered_VBD ,_, diabetics_NNS may_MD not_RB
        be_VB able_JJ to_TO clear_JJ pathogens_NNS as_RB well_RB as_IN non-diabetics_JJ [_NN 1_CD 6_CD 7_CD
        31_CD ]_NN ._. Hyperglycemic_NNP individuals_NNS may_MD also_RB have_VB increased_VBN
        risk_NN for_IN 
        Candida_NNP colonization_NN because_IN their_PRP$
        secretions_NNS contain_VBP glucose_NN ,_, which_WDT can_MD serve_VB as_IN nutrients_NNS
        for_IN 
        Candida_NNP organisms_NNS ._. Sobel_NNP and_CC
        colleagues_NNS reported_VBD a_DT fucose_NN (_( 6_CD -_: deoxy-galactose_JJ )_) vaginal_JJ
        epithelial_NN cell_NN receptor_NN that_IN aids_NNS in_IN adhesion_NN of_IN 
        Candida_NNP to_TO vaginal_JJ epithelial_NN cells_NNS [_NN
        32_CD ]_NN ._. Since_IN fucose_NN contains_VBZ an_DT isomer_NN of_IN glucose_NN and_CC acts_NNS
        as_IN one_CD form_NN of_IN receptor_NN site_NN for_IN 
        Candida_NNP adhesion_NN ,_, it_PRP is_VBZ possible_JJ that_WDT
        increased_VBD 
        Candida_NNP colonization_NN is_VBZ proportional_JJ
        to_TO glucose_NN level_NN ._. Receptor_NNP avidity_NN may_MD be_VB a_DT reflection_NN of_IN
        increased_VBN glucose_NN levels_NNS in_IN the_DT blood_NN and_CC tissues_NNS ._.
        Glycemia_NNP ,_, however_RB ,_, does_VBZ not_RB fully_RB explain_VB the_DT observed_VBD
        increased_VBN risk_NN of_IN 
        Candida_NNP colonization_NN ._.
        We_PRP found_VBD a_DT borderline_NN significant_JJ association_NN with_IN
        performing_VBG oral_JJ sex_NN associated_VBN with_IN an_DT almost_RB five-fold_JJ
        increase_NN in_IN vaginal_JJ colonization_NN with_IN 
        Candida_NNP ._. Receiving_NNP but_CC not_RB performing_VBG
        oral_JJ sex_NN has_VBZ been_VBN previously_RB reported_VBN as_IN a_DT risk_NN factor_NN for_IN
        VVC_NNP [_NN 15_CD ]_NN ._. Oral_NNP sex_NN may_MD facilitate_VB transmission_NN of_IN yeast_NN ,_,
        as_IN 
        Candida_NNP often_RB colonizes_NNS the_DT oral_JJ
        cavity_NN [_NN 15_CD 33_CD ]_NN ._. Diabetics_NNP may_MD be_VB more_RBR likely_JJ to_TO carry_VB
        Candida_NNP in_IN the_DT oral_JJ cavity_NN than_IN their_PRP$ sex_NN partner_NN ;_: thus_RB ,_,
        performing_VBG oral_JJ sex_NN on_IN their_PRP$ sex_NN partner_NN prior_RB to_TO vaginal_JJ
        intercourse_NN may_MD serve_VB to_TO inoculate_NN the_DT vaginal_JJ cavity_NN ._.
        Douching_NNP has_VBZ also_RB been_VBN previously_RB associated_VBN with_IN 
        Candida_NNP colonization_NN [_NN 17_CD 19_CD 20_CD ]_NN ._.
        The_DT practice_NN is_VBZ hypothesized_VBN to_TO disrupt_VB vaginal_JJ flora_NNS ;_:
        vaginal_JJ symptoms_NNS may_MD also_RB lead_VB a_DT women_NNS to_TO douche_NN so_IN the_DT
        direction_NN of_IN effect_NN is_VBZ unclear_JJ ._. The_DT association_NN we_PRP observed_VBD
        with_IN chlamydia_NN is_VBZ probably_RB a_DT marker_NN of_IN sexual_JJ behavior_NN
        rather_RB than_IN a_DT causal_NN factor_NN ;_: for_IN example_NN ,_, women_NNS who_WP
        reported_VBD a_DT history_NN of_IN chlamydia_NN were_VBD more_RBR likely_JJ to_TO douche_NN
        and_CC to_TO report_VB engaging_VBG in_IN oral_JJ sex_NN ,_, although_IN it_PRP is_VBZ possible_JJ
        that_DT chlamydia_NN carriage_NN adversely_RB affects_VBZ the_DT vaginal_JJ flora_NNS
        increasing_VBG the_DT chance_NN of_IN 
        Candida_NNP colonization_NN ._. Recent_JJ
        antibiotic_JJ use_NN is_VBZ a_DT well-described_JJ correlate_VBP of_IN symptomatic_JJ
        
        Candida_NNP vaginitis_NNS [_NN 3_CD 15_CD 16_CD 17_CD 18_CD 34_CD
        ]_NN ._. While_IN asymptomatic_JJ infection_NN is_VBZ not_RB equivalent_JJ to_TO
        disease_NN ,_, antibiotic_JJ use_NN may_MD act_VB to_TO alter_VB the_DT vaginal_JJ
        microenvironment_NN to_TO facilitate_VB 
        Candida_NNP colonization_NN in_IN the_DT same_JJ way_NN
        it_PRP is_VBZ hypothesized_VBN to_TO promote_VB VVC_NNP ._.
        Women_NNP aged_VBN 45_CD years_NNS and_CC older_JJR in_IN our_PRP$ study_NN were_VBD more_RBR
        likely_JJ to_TO be_VB colonized_JJ with_IN 
        Candida_NNP species_NNS ._. We_PRP are_VBP unaware_JJ of_IN
        colonization_NN studies_NNS in_IN women_NNS of_IN comparable_JJ age_NN ;_: most_JJS have_VBP
        emphasized_VBN women_NNS of_IN childbearing_VBG age_NN [_NN 8_CD 35_CD 36_CD ]_NN ._. Whether_IN
        our_PRP$ observation_NN is_VBZ a_DT real_JJ finding_NN or_CC a_DT reflection_NN of_IN our_PRP$
        age_NN distribution_NN (_( 18_CD -_: 84_CD )_) or_CC unknown_JJ selection_NN biases_NNS which_WDT
        led_VBD to_TO inclusion_NN in_IN our_PRP$ study_NN requires_VBZ further_JJ
        investigation_NN ._. However_RB ,_, incidence_NN of_IN symptomatic_JJ infection_NN
        is_VBZ higher_JJR in_IN younger_JJR (_( 18_CD -_: 44_CD )_) women_NNS [_NN 15_CD ]_NN ._.
        This_DT study_NN is_VBZ small_JJ and_CC was_VBD intended_VBN to_TO be_VB hypothesis_NNS
        generating_NN ._. The_DT study_NN population_NN is_VBZ in_IN no_DT way_NN
        representative_NN of_IN all_DT females_NNS with_IN diabetes_NN ,_, although_IN the_DT
        age_NN and_CC racial_JJ distribution_NN of_IN participants_NNS reflected_VBD that_IN
        of_IN the_DT participating_VBG clinics_NNS ._. Although_IN it_PRP is_VBZ possible_JJ that_IN
        women_NNS with_IN a_DT history_NN of_IN symptomatic_JJ infection_NN might_MD have_VB
        been_VBN more_RBR likely_JJ to_TO participate_VB ,_, we_PRP have_VBP no_DT reason_NN to_TO
        believe_VB that_IN women_NNS differentially_RB participated_VBN by_IN both_DT
        symptomatic_JJ history_NN and_CC other_JJ variables_NNS under_IN study_NN which_WDT
        would_MD have_VB biased_VBN our_PRP$ results_NNS ._. Further_RB ,_, as_IN women_NNS were_VBD
        unaware_JJ of_IN whether_IN they_PRP carried_VBD 
        Candida_NNP at_IN the_DT time_NN of_IN completing_VBG the_DT
        questionnaire_NN ,_, it_PRP seems_VBZ unlikely_JJ that_IN a_DT differential_NN recall_NN
        of_IN behaviors_NNS among_IN colonized_JJ and_CC non-colonized_JJ might_MD have_VB
        occurred_VBN ._. A_DT final_JJ concern_NN is_VBZ that_IN 
        Candida_NNP colonization_NN ,_, while_IN the_DT first_JJ
        step_NN toward_IN VVC_NNP ,_, is_VBZ not_RB equivalent_JJ to_TO symptomatic_JJ
        infection_NN ._. Larger_NNP ,_, more_RBR definitive_JJ studies_NNS ,_, which_WDT include_VBP a_DT
        non-diabetic_JJ control_NN group_NN and_CC prospective_JJ follow-up_JJ ,_, are_VBP
        planned_VBN ._.
      
      
        Conclusions_NNP
        We_PRP found_VBD strong_JJ ,_, statistically_RB significant_JJ associations_NNS
        between_IN vaginal_JJ 
        Candida_NNP colonization_NN and_CC antibiotic_JJ
        use_NN ,_, lifetime_NN history_NN of_IN chlamydia_NN ,_, diabetes_NN type_NN and_CC HbA_NNP 
        1_CD c_SYM level_NN and_CC a_DT borderline_NN significant_JJ
        association_NN with_IN performing_VBG oral_JJ sex_NN ._. More_RBR 
        non-albicans_JJ species_NNS were_VBD observed_VBN
        among_IN women_NNS with_IN type_NN 2_CD diabetes_NN ._. Improving_NN glucose_NN control_NN
        and_CC possibly_RB modifying_VBG sexual_JJ behavior_NN may_MD reduce_VB risk_NN of_IN 
        Candida_NNP colonization_NN ,_, and_CC potentially_RB
        symptomatic_JJ infection_NN ,_, among_IN women_NNS with_IN diabetes_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
